Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Deutsche Venture Capital Information
Geographic Data
Address:
City:
State:
Zip:
Country:
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
DVC Deutsche Venture Capital, a venture capitalist based in Munich, focuses primarily on European growth companies in the areas of information, telecommunication, semiconductor and industrial technologies as well as life sciences. In the field of life sciences DVC invests in the development of therapeutic and diagnostic products as well as in platform and medical technologies. DVC’s total administrated fund volume amounts to 300 million Euro. For investments in private companies, DVC invests approximately 1 - 10 million Euro as lead investor or, in the case of larger financing rounds, as co-lead investor. DVC is a “value-added” financial investor. Each sector team consists of experienced investment managers with relevant backgrounds. Since its formation in 1998, DVC has invested in approximately 70 companies.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 11/2003 | Roche Glycart | Series A | 13.6M |
| 4/2001 | Develogen AG | Series B | 0 |
| 1/2005 | VoluBill | Series C | 0 |
| 1/2005 | Powerlase Photonics | Series B | 0 |
| 8/2001 | Onix Microsystems | Series C | 95M |
| 8/2005 | Dolthera GmbH | Series B | 18M |
| 4/2009 | KeyNeurotek Pharmaceuticals | Series C | 10.9M |
| 9/2002 | Cardion | Venture Round | 11.3M |
| 12/2000 | 4SC | Series B | 15M |
| 3/2001 | BigMachines | Series B | 29M |
| 9/2005 | Panoratio | Series B | 5.6M |
| 11/2000 | Epigenomics | Venture Round | 24.1M |
| 5/2008 | MergeOptics | Series D | 8.3M |
| 4/2003 | Epigenomics | Series C | 22.5M |
| 2/2006 | Apertio | Series B | 30M |
| 1/2002 | Hyperwave | Venture Round | 18M |
| 9/2007 | VoluBill | Series D | 0 |
| 5/2003 | 4SC | Series C | 10.5M |
| 1/2005 | PHOENIX CONTACT Cyber Security AG | Series B | 5.2M |
| 10/2000 | End2End Holdings | Private Equity Round | 110M |
| 10/2012 | Panoratio | Venture Round | 0 |
| 10/2012 | Panoratio | Venture Round | 0 |
| 4/2009 | KeyNeurotek Pharmaceuticals | Series C | 0 |
| 5/2008 | MergeOptics | Series D | 0 |
| 9/2007 | VoluBill | Series D | 0 |
| 2/2006 | Apertio | Series B | 0 |
| 9/2005 | Panoratio | Series B | 0 |
| 8/2005 | Dolthera GmbH | Series B | 0 |
| 1/2005 | Powerlase Photonics | Series B | 0 |
| 1/2005 | VoluBill | Series C | 0 |
| 1/2005 | PHOENIX CONTACT Cyber Security AG | Series B | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
